Pharmabiz1h
Relief Therapeutics provides update on potential transaction with Renexxion
Relief Therapeutics Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, provided an update on the potential ...
Pharmabiz2h
Assembly Bio announces interim phase 1b results from trial evaluating next-generation CAM candidate ABI-4334 in chronic hepatitis B
South San Francisco, California Saturday, December 28, 2024, 17:00 Hrs [IST] ...
Pharmabiz4h
US FDA proposes rule to require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products
US FDA proposes rule to require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products: Maryland Saturday, December 28, 2024, 15: ...
Pharmabiz3h
Hoth Therapeutics partners with the Department of Veterans Affairs to develop obesity treatment
Hoth Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies, announced that it has entered into an exclusive patent license agreement with the US Department of ...
Pharmabiz6h
Chugai Pharma receives Japanese regulatory approval for Lunsumio for intravenous infusion for relapsed/refractory follicular lymphoma
Chugai Pharma receives Japanese regulatory approval for Lunsumio for intravenous infusion for relapsed/refractory follicular lymphoma: Tokyo Saturday, December 28, 2024, 13:00 Hrs ...
Pharmabiz5h
Exicure joins hands with GPCR Therapeutics for growth in biotech
Exicure joins hands with GPCR Therapeutics for growth in biotech: Chicago Saturday, December 28, 2024, 14:00 Hrs [IST] Exicure, Inc., an early-stage biotechnology company, has ann ...
Pharmabiz10h
Big data transforming healthcare and enabling better patient outcomes, operational efficiencies: Rahul Bajaj
Big data transforming healthcare and enabling better patient outcomes, operational efficiencies: Rahul Bajaj: Our Bureau, Bengaluru Saturday, December 28, 2024, 09:00 Hrs [IST] Bi ...
Pharmabiz9h
Takeda gets Japanese MHLW approval for Hyqvia 10% SC injection for patients with agammaglobulinemia or hypogammaglobulinemia
Takeda gets Japanese MHLW approval for Hyqvia 10% SC injection for patients with agammaglobulinemia or hypogammaglobulinemia: Osaka, Japan Saturday, December 28, 2024, 10:00 Hrs [ ...
Pharmabiz11h
Parliamentary panel asks NPPA to submit detailed note on 50% price hike on 11 drugs
Parliamentary panel asks NPPA to submit detailed note on 50% price hike on 11 drugs: Gireesh Babu, New Delhi Saturday, December 28, 2024, 08:00 Hrs [IST] A Parliamentary panel has ...
Pharmabiz6h
Advanced devices & innovative therapies offer new hope in India's heart care revolution: Dr Nagesh Waghmare
The integration of advanced technology into cardiac care is transforming the treatment of heart failure, according to Dr Nagesh S Waghmare, Interventional Cardiologist at Bombay Hospital and Medical ...
Pharmabiz6h
India plays a significant role in global MedTech sector especially in emerging markets: Arpit Paliwal
India is playing an increasingly significant role in the global MedTech sector. As the demand for medical technologies rises, especially in emerging markets, India is well-positioned to meet these ...
Pharmabiz8h
Viracta Therapeutics announces closure of NAVAL-1 trial and exploration of strategic alternatives
Viracta Therapeutics announces closure of NAVAL-1 trial and exploration of strategic alternatives: San Diego Saturday, December 28, 2024, 11:00 Hrs [IST] Viracta Therapeutics, Inc ...